Source: MedGen UID: 52069
Camostat is a serine protease inhibitor used in the
treatment of cancer, viral infections, liver, kidney
and pancreatic disease.
SARS Coronavirus Protease Pathway
32142651 SARS-CoV-2 Cell Entry Depends
on ACE2 and TMPRSS2 and Is Blocked by
a Clinically Proven Protease Inhibitor.
30920846 Intestinal serine protease inhibition
increases FGF21 and improves metabolism in
30623107 Hepatocyte growth factor activator
inhibitor-2 stabilizes Epcam and maintains
epithelial organization in the mouse intestine.
30391941 Camostat Mesilate, Pancrelipase,
and Rabeprazole Combination Therapy
Improves Epigastric Pain in Early Chronic
Pancreatitis and Functional Dyspepsia with
Pancreatic Enzyme Abnormalities.
26166259 The serine protease inhibitor
camostat inhibits influenza virus replication and
cytokine production in primary cultures of
human tracheal epithelial cells.
25766432 The serine protease inhibitor
camostat mesilate attenuates the progression
of chronic kidney disease through its
25666761 Protease inhibitors targeting
coronavirus and filovirus entry.
22038264 Proteolytic activation of the epithelial
sodium channel and therapeutic application of a
serine protease inhibitor for the treatment of
11779708 Retinoids in liver fibrosis and cancer.
6209186 Effect of a specific
serine protease inhibitor on the rat pancreas:
systemic administration of camostate and
exocrine pancreatic secretion.
⇧ Embed Print